Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pierce, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 152 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Giles, FJ; Shen, Y; Kantarjian, HM; Korbling, MJ; O'Brien, S; Anderlini, P; Donato, M; Pierce, S; Keating, MJ; Freireich, EJ; Estey, E
      Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival

      LEUKEMIA & LYMPHOMA
    2. Fleming, RV; Kantarjian, HM; Husni, R; Rolston, K; Lim, J; Raad, I; Pierce, S; Cortes, J; Estey, E
      Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia

      LEUKEMIA & LYMPHOMA
    3. Galantai, A; Pierce, S
      Rank reduction, factorization and conjugation

      LINEAR & MULTILINEAR ALGEBRA
    4. Cha, S; Pierce, S; Knopp, EA; Johnson, G; Yang, C; Ton, A; Litt, AW; Zagzag, D
      Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions

      AMERICAN JOURNAL OF NEURORADIOLOGY
    5. Albitar, M; Manshouri, T; Gidel, C; Croce, C; Kornblau, S; Pierce, S; Kantarjian, HM
      Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia

      LEUKEMIA RESEARCH
    6. Pierce, S
      A curious & ingenious art: Reflections on Daguerreotypes at Harvard

      NEW ENGLAND QUARTERLY-A HISTORICAL REVIEW OF NEW ENGLAND LIFE AND LETTERS
    7. Bennett, BL; Sasaki, DT; Murray, BW; O'Leary, EC; Sakata, ST; Xu, WM; Leisten, JC; Motiwala, A; Pierce, S; Satoh, Y; Bhagwat, SS; Manning, AM; Anderson, DW
      SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. Li, CK; Pierce, S
      Linear preserver problems

      AMERICAN MATHEMATICAL MONTHLY
    9. Pierce, S; Maxwell, K; Griffiths, H; Winter, K
      Hydrophobic trichome layers and epicuticular wax powders in Bromeliaceae

      AMERICAN JOURNAL OF BOTANY
    10. Giles, FJ; Wong, GC; Clark, SJ; Pierce, S; Kantarjian, HM; Keating, MJ
      Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemia

      LEUKEMIA & LYMPHOMA
    11. Faderl, S; Kantarjian, HM; Thomas, DA; Cortes, J; Giles, F; Pierce, S; Albitar, M; Estrov, Z
      Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia

      LEUKEMIA & LYMPHOMA
    12. Kantarjian, HM; O'Brien, S; Smith, TL; Cortes, J; Giles, FJ; Beran, M; Pierce, S; Huh, Y; Andreeff, M; Koller, C; Ha, CS; Keating, MJ; Murphy, S; Freireich, EJ
      Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    13. Estey, EH; Pierce, S; Keating, MJ
      Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities

      HAEMATOLOGICA
    14. Keyhani, A; Huh, YO; Jendiroba, D; Pagliaro, L; Cortez, J; Pierce, S; Pearlman, M; Estey, E; Kantarjian, H; Freireich, EJ
      Increased CD38 expression is associated with favorable prognosis in adult acute leukemia

      LEUKEMIA RESEARCH
    15. Mehndiratta, S; Kemp, M; Pierce, S; Lappin, J
      Users of a regional telephone-based traveler information system - a study of TravInfo (TM) users in the San Francisco Bay Area

      TRANSPORTATION
    16. Jambunathan, S; Burts, DC; Pierce, S
      Comparisons of parenting attitudes among five ethnic groups in the United States

      JOURNAL OF COMPARATIVE FAMILY STUDIES
    17. Pierce, S; Stirling, CM; Baxter, R
      Architectural and physiological heterogeneity within the synflorescence ofthe pseudoviviparous grass Poa alpina var. vivipara L.

      JOURNAL OF EXPERIMENTAL BOTANY
    18. Pierce, S; Stirling, CM; Baxter, R
      The influence of secondary senescence processes within the culm of a pseudoviviparous grass (Poa alpina var. vivipara L.) on the supply of water to propagules

      JOURNAL OF EXPERIMENTAL BOTANY
    19. Faderl, S; Kantarjian, HM; Estey, E; Manshouri, T; Chan, CY; Elsaied, AR; Kornblau, SM; Cortes, J; Thomas, DA; Pierce, S; Keating, MJ; Estrov, Z; Albitar, M
      The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia

      CANCER
    20. Kaban, K; Kantarjian, H; Talpaz, M; O'Brien, S; Cortes, J; Giles, FJ; Pierce, S; Albitar, M
      Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia - Correlation with disease progression and response to therapy

      CANCER
    21. Ibrahim, S; Estey, EH; Pierce, S; Glassman, A; Keating, M; O'Brien, S; Kantarjian, HM; Albitar, M
      11q23 Abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses

      AJCP. American journal of clinical pathology
    22. Faderl, S; Estrov, Z; Kantarjian, HM; Thomas, D; Cortes, J; Manshouri, T; Chan, CC; Hays, KJ; Pierce, S; Albitar, M
      The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    23. Faderl, S; Kantarjian, HM; Manshouri, T; Chan, CY; Pierce, S; Hays, KJ; Cortes, J; Thomas, D; Estrov, Z; Albitar, M
      The prognostic significance of p16(INK4a)/p14(ARF) and p15(INK4b) deletions in adult acute lymphoblastic leukemia

      CLINICAL CANCER RESEARCH
    24. Faderl, S; Thall, PF; Kantarjian, HM; Talpaz, M; Harris, D; Van, Q; Beran, M; Kornblau, SM; Pierce, S; Estrov, Z
      Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia

      CLINICAL CANCER RESEARCH
    25. Estey, EH; Thall, PF; Reed, P; Kantarjian, H; Beran, M; Pierce, S; Keating, MJ
      Treatment of newly diagnosed AML, RAEB-t or RAEB with lisofylline or placebo in addition to chemotherapy

      LEUKEMIA
    26. Dabaja, BS; Faderl, S; Thomas, D; Cortes, J; O'Brien, S; Nasr, F; Pierce, S; Hayes, K; Glassman, A; Keating, M; Kantarjian, HM
      Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications

      LEUKEMIA
    27. Thomas, DA; Cortes, J; O'Brien, S; Pierce, S; Faderl, S; Albitar, M; Hagemeister, FB; Cabanillas, FF; Murphy, S; Keating, MJ; Kantarjian, H
      Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    28. Murray, CK; Estey, E; Paietta, E; Howard, RS; Edenfield, WJ; Pierce, S; Mann, KP; Bolan, C; Byrd, JC
      CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome?

      JOURNAL OF CLINICAL ONCOLOGY
    29. Albitar, M; Manshouri, T; Kantarjian, H; Keating, M; Estrov, Z; Faber, J; Freireich, EJ; Pierce, S; Estey, E
      Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia

      LEUKEMIA RESEARCH
    30. Albitar, M; Chang, KS; Pierce, S; Kantarjian, H; Estey, E
      The short form of PML-RAR alpha fusion transcript is associated with poor survival

      LEUKEMIA RESEARCH
    31. Pierce, S
      Congruence of polynomial matrices

      LINEAR ALGEBRA AND ITS APPLICATIONS
    32. Aguayo, A; Cortes, J; Thomas, D; Pierce, S; Keating, M; Kantarjian, H
      Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia

      CANCER
    33. Thomas, DA; Kantarjian, H; Smith, TL; Koller, C; Cortes, J; O'Brien, S; Giles, FJ; Gajewski, J; Pierce, S; Keating, MJ
      Primary refractory and relapsed adult acute lymphoblastic leukemia - Characteristics, treatment results, and prognosis with salvage therapy

      CANCER
    34. Estey, EH; Thall, PF; Pierce, S; Cortes, J; Beran, M; Kantarjian, H; Keating, MJ; Andreeff, M; Freireich, E
      Randomized phase II study of fludarabine plus cytosine arabinoside plus idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

      BLOOD
    35. Issa, JPJ; Kantarjian, H; Mohan, A; O'Brien, S; Cortes, J; Pierce, S; Talpaz, M
      Methylation of the ABL1 promoter in chronic myelogenous leukemia: Lack of prognostic significance

      BLOOD
    36. WILHELM M; BUESORAMOS C; OBRIEN S; PIERCE S; KEATING M; TALPAZ M; KANTARJIAN HM
      EFFECT OF INTERFERON-ALPHA THERAPY ON BONE-MARROW FIBROSIS IN CHRONICMYELOGENOUS LEUKEMIA

      Leukemia
    37. SACCHI S; KANTARJIAN HM; SMITH TL; OBRIEN S; PIERCE S; KORNBLAU S; BERAN M; KEATING MJ; TALPAZ M
      EARLY TREATMENT DECISIONS WITH INTERFERON-ALPHA THERAPY IN EARLY CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA

      Journal of clinical oncology
    38. James, G; Johnson, C; Pierce, S
      Generalized matrix function inequalities on M-matrices

      JOURNAL OF THE LONDON MATHEMATICAL SOCIETY-SECOND SERIES
    39. POLLAK PT; PIERCE S; COOKE C
      AMRINONE AND AMIODARONE - SERIOUS CONFUSION IN THE INTRAVENOUS LINE

      Archives of internal medicine
    40. DELIMA M; ALBITAR M; OBRIEN S; PIERCE S; KANTARJIAN H; ANDREEFF M; FAYAD L; KEATING M; ESTEY E
      COMPARISON OF REFERRING AND TERTIARY CANCER CENTER PHYSICIANS DIAGNOSES IN PATIENTS WITH LEUKEMIA

      The American journal of medicine
    41. HOFF PM; PIERCE S; ESTEY E
      COMPARISON OF ACUTE MYELOID-LEUKEMIA PATIENTS AT MD ANDERSON - 1982-1986 VS 1992-1996

      Leukemia
    42. SACCHI S; KANTARJIAN HM; OBRIEN S; BERAN M; KOLLER C; PIERCE S; KORNBLAU S; ESTEY E; KEATING MJ; TALPAZ M
      LONG-TERM FOLLOW-UP RESULTS OF ALPHA-INTERFERON-BASED REGIMENS IN PATIENTS WITH LATE CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA

      Leukemia
    43. ESTEY E; THALL P; KANTARJIAN H; PIERCE S; KORNBLAU S; KEATING M
      ASSOCIATION BETWEEN INCREASED BODY-MASS INDEX AND A DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Leukemia
    44. DELONG MA; JEE W; JANKOWSKY M; SOEHNER M; PIERCE S; MA YF; HARTKE J; LUNDY M
      BONE ANABOLIC EFFECTS OF PGE1 IN AGED, OVARIECTOMIZED RATS MEASURED BY DXA, PQCT AND HISTOLOGY

      Journal of bone and mineral research
    45. ESTEY E; THALL PF; PIERCE S; KANTARJIAN H; KEATING M
      COMPARING AN APPLE TO A FRUIT SALAD - REPLY

      Journal of clinical oncology
    46. ESTEY E; THALL PF; PIERCE S; KANTARJIAN H; KEATING M
      TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA WITHOUT CYTARABINE

      Journal of clinical oncology
    47. KOWALSKI MA; PIERCE S; EDWARDS RL; ETHIRAJAN S; RYAN K
      HEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-TC-A

      Transfusion
    48. HENDERSON JM; MCCLURE KK; PIERCE S; SCHROCK G
      OBJECT IDENTIFICATION WITHOUT FOVEAL VISION - EVIDENCE FROM AN ARTIFICIAL SCOTOMA PARADIGM

      Perception & psychophysics
    49. GUNNAR MR; TOUT K; DEHAAN M; PIERCE S; STANSBURY K
      TEMPERAMENT, SOCIAL COMPETENCE, AND ADRENOCORTICAL ACTIVITY IN PRESCHOOLERS

      Developmental psychobiology
    50. KIMELMAN D; FARR H; YOST C; PIERCE S
      REGULATION OF DORSAL AXIS FORMATION IN XENOPUS BY A NOVEL GSK-3 BINDING-PROTEIN

      Developmental biology
    51. ESTEY E; DELIMA M; STROM S; PIERCE S; FREIREICH EJ; KEATING MJ
      LONG-TERM FOLLOW-UP OF PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA TREATED AT THE UNIVERSITY-OF-TEXAS M.-D.-ANDERSON-CANCER-CENTER

      Cancer
    52. ESTEY E; THALL P; BERAN M; KANTARJIAN H; PIERCE S; KEATING M
      EFFECT OF DIAGNOSIS (REFRACTORY-ANEMIA WITH EXCESS BLASTS, REFRACTORY-ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION, OR ACUTE MYELOID-LEUKEMIA [AML]) ON OUTCOME OF AML-TYPE CHEMOTHERAPY

      Blood
    53. ESTEY E; KEATING M; PIERCE S; BERAN M
      APPLICATION OF THE INTERNATIONAL SCORING SYSTEM FOR MYELODYSPLASIA TOM.D.-ANDERSON PATIENTS

      Blood
    54. DELIMA M; STROM SS; KEATING M; KANTARJIAN H; PIERCE S; OBRIEN S; FREIREICH E; ESTEY E
      IMPLICATIONS OF POTENTIAL CURE IN ACUTE MYELOGENOUS LEUKEMIA - DEVELOPMENT OF SUBSEQUENT CANCER AND RETURN TO WORK

      Blood
    55. DABAJA B; KANTARJIAN H; PIERCE S; KEATING M; ESTEY E
      THE OUTCOME OF FUO DURING INDUCTION THERAPY OF AML MDS/

      Blood
    56. THOMAS D; KANTARJIAN H; OBRIEN S; KEATING MJ; KOLLER C; BERAN M; ESTEY E; PIERCE S; FREIREICH E
      REFRACTORY OR RELAPSED BURKITTS TYPE ADULT LYMPHOBLASTIC-LEUKEMIA (ALL) - CHARACTERISTICS AND OUTCOME WITH SALVAGE THERAPY

      Blood
    57. THOMAS D; KANTARJIAN H; KOLLER C; OBRIEN S; KEATING MJ; BERAN M; ESTEY E; PIERCE S; FREIREICH E
      REVIEW OF 43 PATIENTS (PTS) WITH ADULT LYMPHOBLASTIC-LEUKEMIA (ALL) IN RELAPSE AFTER INITIAL CR DURATION GREATER-THAN-2 YEARS - CHARACTERISTICS, RESPONSE AND OUTCOME WITH SALVAGE THERAPY

      Blood
    58. KANTARJIAN H; MANSHOURI PT; ESTROV Z; TALPAZ M; OBRIEN S; BERAN M; PIERCE S; ESTEY E; KEATING M; ALBITAR M
      SIGNIFICANCE OF C-MPL EXPRESSION IN PHILADELPHIA-CHROMOSOME (PH)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML)

      Blood
    59. ALBITAR M; MANSHOURI T; KANTARJIAN H; KEATING M; ESTROV Z; FABER J; FREIREICH E; PIERCE S; ESTEY E
      FAVORABLE CYTOGENETIC GROUPS IN ACUTE MYELOID-LEUKEMIA (AML) DO NOT OVEREXPRESS C-MPL PROTEIN

      Blood
    60. RAVANDI F; KEATING M; PIERCE S; ESTEY E
      IDENTIFICATION OF A RELATIVELY FAVORABLE GROUP WITHIN AML MDS PTS WITH CHROMOSOME-5 AND/OR 7 ABNORMALITIES/

      Blood
    61. CORTES J; KANTARJIAN H; KEATING M; OBRIEN S; RODRIGUEZ J; PIERCE S; ESTEY E
      BETA-2-MICROGLOBULIN (B2M) IS A SIGNIFICANT PROGNOSTIC FACTOR FOR OUTCOME OF PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA(AML) AND MYELODYSPLASTIC SYNDROME (MDS)

      Blood
    62. ESTEY E; THALL P; KANTARJIAN H; PIERCE S; KEATING M
      THE VALUE OF CR IN NEWLY-DIAGNOSED AML

      Blood
    63. ISSA JP; KANTARJIAN H; MOHAN A; OBRIEN S; CORTES J; PIERCE S; TALPAZ M
      METHYLATION OF C-ABL PROMOTER - A PROGNOSTIC FACTOR IN CHRONIC MYELOGENOUS LEUKEMIA (CML)

      Blood
    64. ESTEY E; BERAN M; PIERCE S; KANTARJIAN H; KEATING M
      ALL-TRANS-RETINOIC ACID (ATRA) MAY IMPROVE RESULTS OF CHEMOTHERAPY INPOOR-PROGNOSIS NON-APL AML AND MDS - A RANDOMIZED STUDY

      Blood
    65. KANTARJIAN H; MANSHOURI T; TALPAZ M; OBRIEN S; KEATING M; CORTES J; PIERCE S; ANDREEFF M; KORNBLAU S; ALBITAR M
      MULTIDRUG-RESISTANCE (MDR) EXPRESSION IN CHRONIC MYELOGENOUS LEUKEMIA(CML)

      Blood
    66. ESTEY E; DAHLBERG S; KANTARJIAN H; REED P; PIERCE S; MACPHERSON B; BIANCO J; SINGER J; KEATING M
      RANDOMIZED TRIAL OF IDARUBICIN PLUS ARA-C + -LISOFYLLINE IN NEWLY-DISGNOSED AML/MDS/

      Blood
    67. SACCHI S; KANTARJIAN K; SMITH T; OBRIEN S; PIERCE S; KORNBLAU S; BERAN M; KEATING M; TALPAZ M
      EARLY TREATMENT DECISIONS WITH INTERFERON-ALPHA (IFN-A) THERAPY IN EARLY CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CP-CML)

      Blood
    68. FAYAD L; KURZROCK R; KEATING M; OBRIEN S; KANTARJIAN H; ANDREEFF M; PIERCE S; TALPAZ M; FREIREICH E; ESTEY E
      TREATMENT OF HAIRY-CELL LEUKEMIA (HCL) WITH 2-CDA - LONG-TERM FOLLOW-UP AT M.D.-ANDERSON-CANCER-CENTER

      Blood
    69. BERAN M; KANTARJIAN H; KEATING M; OBRIEN S; PIERCE S; KOLLER C; CORTES J; ANDREEFF M; KORNBLAU S; ESTEY E
      RESULTS OF COMBINATION CHEMOTHERAPY WITH TOPOTECAN AND HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN PREVIOUSLY UNTREATED PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

      Blood
    70. GHADDAR HM; PIERCE S; KANTARJIAN HM; FREIREICH EJ; KEATING MJ; ESTEY EH
      AMSACRINE AND CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE AS INDUCTION THERAPY FOR PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA

      Leukemia & lymphoma
    71. SARRIS A; CORTES J; KANTARJIAN H; PIERCE S; SMITH T; KEATING M; KOLLER C; KORNBLAU S; OBRIEN S; ANDREEFF M
      DISSEMINATED INTRAVASCULAR COAGULATION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - FREQUENT COMPLICATIONS WITH FIBRINOGEN LEVELS LESS-THAN 100 MG DL/

      Leukemia & lymphoma
    72. ANDERLINI P; GHADDAR HM; SMITH TL; PIERCE S; KANTARJIAN HM; OBRIEN S; KEATING MJ; FREIREICH EJ; ESTEY EH
      FACTORS PREDICTING COMPLETE REMISSION AND SUBSEQUENT DISEASE-FREE SURVIVAL AFTER A 2ND COURSE OF INDUCTION THERAPY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RESISTANT TO THE FIRST

      Leukemia
    73. ANDERLINI P; LUNA M; KANTARJIAN HM; OBRIEN S; PIERCE S; KEATING MJ; ESTEY EH
      CAUSES OF INITIAL REMISSION INDUCTION FAILURE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

      Leukemia
    74. ESCUDIER SM; ALBITAR M; ROBERTSON LE; ANDREEFF M; PIERCE S; KANTARJIAN HM
      ACUTE LYMPHOBLASTIC-LEUKEMIA FOLLOWING PRELEUKEMIC SYNDROMES IN ADULTS

      Leukemia
    75. WILHELM M; KANTARJIAN HM; OBRIEN S; PIERCE S; KEATING MJ; FREIREICH EJ; ESTEY EH
      PNEUMONIA DURING REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS WITH AML OR MDS

      Leukemia
    76. POLLICARDO N; OBRIEN S; ESTEY EH; ALBITAR M; PIERCE S; KEATING M; KANTARJIAN HM
      SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA - CHARACTERISTICS AND PROGNOSIS OF 14 PATIENTS FROM A SINGLE INSTITUTION

      Leukemia
    77. DALTON JA; BLAU W; CARLSON J; MANN JD; BERNARD S; TOOMEY T; PIERCE S; GERMINO B
      CHANGING THE RELATIONSHIP AMONG NURSES KNOWLEDGE, SELF-REPORTED BEHAVIOR, AND DOCUMENTED BEHAVIOR IN PAIN MANAGEMENT - DOES EDUCATION MAKE A DIFFERENCE

      Journal of pain and symptom management
    78. ANDERLINI P; PIERCE S; KANTARJIAN H; ESTEY E
      ACUTE MYELOID LEUKEMIA-TYPE CHEMOTHERAPY FOR MYELODYSPLASIA

      Journal of clinical oncology
    79. MCCREADY DJ; PIERCE S; RAHN SL; WERE K
      3RD GENERATION INFORMATION-SYSTEMS - INTEGRATING COSTS AND OUTCOMES -TOOLS FOR PROFESSIONAL-DEVELOPMENT AND PROGRAM-EVALUATION

      Administration in social work
    80. PIERCE S
      CREATING 'PICTURESQUE AMERICA' - MONUMENT TO THE NATURAL AND CULTURALLANDSCAPE - RAINEY,S

      Print quarterly
    81. SCHNITT SJ; HAYMAN J; GELMAN R; EBERLEIN TJ; LOVE SM; MAYZEL K; OSTEEN RT; NIXON AJ; PIERCE S; CONNOLLY JL; COHEN P; SCHNEIDER L; SILVER B; RECHT A; HARRIS JR
      A PROSPECTIVE-STUDY OF CONSERVATIVE SURGERY ALONE IN THE TREATMENT OFSELECTED PATIENTS WITH STAGE-I BREAST-CANCER

      Cancer
    82. DELIMA M; GHADDAR H; PIERCE S; ESTEY E
      TREATMENT OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 80 YEARS AND ABOVE

      British Journal of Haematology
    83. BERAN M; KANTARJIAN H; OBRIEN S; KOLLER C; ALBITAR M; ARBUCK S; PIERCE S; MOORE M; ABBRUZZESE JL; ANDREEFF M; KEATING M; ESTEY E
      TOPOTECAN, A TOPOISOMERASE-I INHIBITOR, IS ACTIVE IN THE TREATMENT OFMYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA

      Blood
    84. ESTEY E; KORNBLAU S; PIERCE S; KANTARJIAN H; BERAN M; KEATING M
      A STRATIFICATION SYSTEM FOR EVALUATING AND SELECTING THERAPIES IN PATIENTS WITH RELAPSED OR PRIMARY REFRACTORY ACUTE MYELOGENOUS LEUKEMIA

      Blood
    85. DELIMA M; ALBITAR M; PIERCE S; FAYAD L; BERAN M; KEATING M; KANTARJIAN H; ESTEY E
      COMPARISON OF REFERRING AND M-D-ANDERSON-PHYSICIANS-DIAGNOSES IN PATIENTS WITH LEUKEMIA

      Blood
    86. ESTEY E; THOMAS X; KEATING M; CHARRIN C; PIERCE S; ARCHIMBAUD E
      COMPARISON OF NEWLY-DIAGNOSED AML IN A FRENCH AND AN AMERICAN ACADEMIC HOSPITAL

      Blood
    87. WILHELM M; KANTARJIAN HM; OBRIEN S; PIERCE S; KEATING MJ; FREIREICH EJ; ESTEY EH
      PNEUMONIA DURING REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS WITH AML OR MDS

      Blood
    88. WILHELM M; RAMOS CM; OBRIEN S; PIERCE S; KEATING M; TALPAZ M; KANTARJIAN H
      EFFECT OF INTERFERON-ALPHA (IFN-A) THERAPY ON BONE-MARROW (BM) FIBROSIS IN CHRONIC MYELOGENOUS LEUKEMIA (CML)

      Blood
    89. THOMAS D; KANTARJIAN H; KEATING MJ; OBRIEN S; PIERCE S; BERAN M; KOLLER C; FREIREICH E
      ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) IN FIRST RELAPSE - CHARACTERISTICS, OUTCOME, AND PROGNOSIS WITH SALVAGE THERAPY

      Blood
    90. ESTEY E; THALL P; PIERCE S; FAYAD L; KORNBLAU S; KANTARJIAN H; KEATING M
      ASSOCIATION BETWEEN INCREASED BODY-MASS INDEX AND A DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Blood
    91. DELIMA M; STROM S; KEATING M; PIERCE S; KANTARJIAN H; FREIREICH E; ESTEY E
      SUBSEQUENT CANCER AND RETURN TO WORK IN PATIENTS (PTS) WITH POTENTIALLY CURED AML

      Blood
    92. ESTEY E; THALL P; KANTARJIAN H; KEATING M; PIERCE S; BERAN M
      DIAGNOSIS OF RAEB OR RAEB-T, RATHER THAN AML, DOES NOT NEGATIVELY INFLUENCE OUTCOME OF ANTI-AML CHEMOTHERAPY

      Blood
    93. ESTEY E; BERAN M; HAYES K; LOVSHE D; KOMBLAU S; PIERCE S; KOLLER C; OBRIEN S; KANTARJIAN H; ANDREEFF M; KEATING M; FREIREICH E
      CYTOGENETIC (CG) AND FLUORESCENT IN-SITU HYBRIDIZATION (FISH) ANALYSIS ON COURSE 1 DAY 21 OF CHEMOTHERAPY (CT) FOR NEWLY-DIAGNOSED AML MDS/

      Blood
    94. ESTEY E; PIERCE S
      ROUTINE BONE-MARROW EXAM DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA

      Blood
    95. CORTES J; KANTARJIAN H; OBRIEN S; ROBERTSON LE; PIERCE S; TALPAZ M
      RESULTS OF INTERFERON-ALPHA THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA 60 YEARS OF AGE AND OLDER

      The American journal of medicine
    96. ESTEY EH; KANTARJIAN HM; OBRIEN S; KORNBLAU S; ANDREEFF M; BERAN M; PIERCE S; KEATING M
      HIGH REMISSION RATE, SHORT REMISSION DURATION IN PATIENTS WITH REFRACTORY-ANEMIA WITH EXCESS BLASTS (RAEB) IN TRANSFORMATION (RAEB-T) GIVENACUTE MYELOGENOUS LEUKEMIA (AML)-TYPE CHEMOTHERAPY IN COMBINATION WITH GRANULOCYTE-CSF (G-CSF)

      Cytokines and molecular therapy
    97. MARLTON P; KEATING M; KANTARJIAN H; PIERCE S; OBRIEN S; FREIREICH EJ; ESTEY E
      CYTOGENETIC AND CLINICAL CORRELATES IN AML PATIENTS WITH ABNORMALITIES OF CHROMOSOME-16

      Leukemia
    98. ESTEY E; KEATING MJ; PIERCE S; STASS S
      CHANGE IN KARYOTYPE BETWEEN DIAGNOSIS AND FIRST RELAPSE IN ACUTE MYELOGENOUS LEUKEMIA

      Leukemia
    99. GHADDAR HM; PIERCE S; REED P; ESTEY EH
      PROGNOSTIC VALUE OF RESIDUAL NORMAL METAPHASES IN ACUTE MYELOGENOUS LEUKEMIA PATIENTS PRESENTING WITH ABNORMAL KARYOTYPE

      Leukemia
    100. CORTES JE; KANTARJIAN H; OBRIEN S; KEATING M; PIERCE S; FREIREICH EJ; ESTEY E
      CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF TRISOMY-21 IN ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

      Leukemia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 03:10:28